Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Keir (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom), M. Crichton (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), J. Pollock (Dundee, United Kingdom), A. Giam (Dundee, United Kingdom), A. Cassidy (Dundee, United Kingdom), C. Fong (Dundee, United Kingdom), S. Finch (Dundee, United Kingdom), E. Furrie (Dundee, United Kingdom), G. Suarez-Cuartin (l'Hospitalet de Llobregat, Spain), T. Fardon (Dundee, United Kingdom), G. Einarsson (Belfast, United Kingdom), J. Elborn (Belfast, United Kingdom), S. Aliberti (Milan, Italy), O. Sibila (Barcelona, Spain), J. Huang (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom). Endotyping bronchiectasis through multi-omic profiling. 4101

Member's Comments

No comment yet.

Related content which might interest you: Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020 “Integrative microbiomics” reveals a disrupted interactome in bronchiectasis exacerbations Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy Year: 2020 Whole metagenome shotgun sequencing analysis of microbiome of cystic fibrosis- and COPD patients Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes Source: Eur Respir J, 59 (1) 2102603; 10.1183/13993003.02603-2021 Year: 2022 Further resolution of non-T2 asthma subtypes from high-throughput sputum transciptomics data in U-BIOPRED Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Discriminating phenotypes of severe eosinophilic asthma using gene profiling in sputum Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018 The landscape of transcriptomic and proteomic studies in sarcoidosis Source: ERJ Open Res, 8 (1) 00621-2021; 10.1183/23120541.00621-2021 Year: 2022 SELDI-TOF biomarkers signatures for cystic fibrosis, asthma and COPD Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Outcome of dedicated immune profiling in adult non-cystic fibrosis bronchiectasis Source: Eur Respir J 2007; 30: Suppl. 51, 529s Year: 2007 Metabolic profiling in pulmonary diseases Source: International Congress 2019 – Metabolic alterations in lung ageing and disease Year: 2019 Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring Source: Eur Respir J 2006; 28: Suppl. 50, 152s Year: 2006 Endotyping of COPD, bronchiectasis and their overlap syndrome by integrated sputum proteome/microbiome Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2019 The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach Source: International Congress 2019 – The microbiome: novel data across respiratory diseases Year: 2019 Application of omics technologies to the identification of biomarkers for COPD Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate Source: ERJ Open Res, 5 (1) 00157-2018; 10.1183/23120541.00157-2018 Year: 2019 Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis Source: Eur Respir J, 52 (5) 1800564; 10.1183/13993003.00564-2018 Year: 2018 New proteomic biomarkers of cystic fibrosis: a comparison with non-CF bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 240s Year: 2005 Inflammatory molecular endotypes in bronchiectasis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Pulmonary transplantation and bronchiolitis obliterans syndrome: characterisation of diagnostic biomarkers in bronchioloalveolar lavage fluid by SELDI-TOF proteomic analysis Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options Year: 2009